India to France: Fenofibrate Export Trade Route

The India to France Fenofibrate corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $4.7M USD. The route is dominated by ABBOTT HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's fenofibrate manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $150.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with fenofibrate's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 17.8%, placing it at rank #1 among India's top fenofibrate export destinations globally.

On the import side, key buyers of Indian fenofibrate in France include MYLAN LABORATORIES SAS, MYLAN LABORATORIES SAS , MYLAN LABORATORIES SAS ROUTE DE BELLEVILLE and 4 others. MYLAN LABORATORIES SAS is the single largest importer with 15 shipments valued at $2.9M USD.

India's fenofibrate exports to France are driven primarily by a handful of large-scale manufacturers. ABBOTT HEALTHCARE PRIVATE LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ABBOTT HEALTHCARE PRIVATE LIMITED, ABBOTT HEALTH CARE PRIVATE LIMITED, ABBOTT HEALTHCARE PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $150.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as fenofibrate tab 145mg batch no. ffc23058 ffc23059ffc23060ffc23061ffc23062 manufacturing dt.07.2023 exp dt.07.2024 and fenofibrate tab.145mg batch no.ffc23006, , suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MYLAN LABORATORIES SAS is the largest importer with 15 shipments worth $2.9M USD — representing 61% of all fenofibrate imports from India on this route. A total of 7 buyers are active on this corridor.